Quality Care
The AI-based early warning system the NHS is developing is part of the government's 10 Year Health Plan to use data to identify patient safety concerns.
Also, a Taiwanese startup has received the US FDA's 510(k) clearance for its neurosurgical robot.
The sale drew mixed reactions, with some U.S. states supporting it as a privacy measure and others objecting over legal and data concerns.
The Polyphonic AI Fund for Surgery will invest in and provide mentorship to AI-enabled platforms aiming to advance surgical innovation.
The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.
The Series E funding comes four months after the company secured $250 million in a Series D round.
Selected early versions will be slated for real-world deployment.
HIMSS25
Dr. Sarah Hoffe, interim GI oncology chair at Moffitt Cancer Center, says telemedicine platforms and other technologies help ease nurse burnout, boost patient adherence and enable focused, personalized patient connections.
Funding from the venture capital firm's Customer Value Fund will allow Commure to accelerate its expansion in healthcare without ownership dilution.
The funding comes on the heels of the fax automation company's $37 million Series B funding round and $18 million Series A raise last year.